Literature DB >> 15385557

Structural and functional characterization of oversulfated chondroitin sulfate/dermatan sulfate hybrid chains from the notochord of hagfish. Neuritogenic and binding activities for growth factors and neurotrophic factors.

Chilkunda D Nandini1, Tadahisa Mikami, Mitsuhiro Ohta, Nobuyuki Itoh, Fumiko Akiyama-Nambu, Kazuyuki Sugahara.   

Abstract

Oversulfated chondroitin sulfate (CS)/dermatan sulfate (DS) hybrid chains were purified from the notochord of hagfish. The chains (previously named CS-H for hagfish) have an average molecular mass of 18 kDa. Composition analysis using various chondroitinases demonstrated a variety of D-glucuronic acid (GlcUA)- and L-iduronic acid (IdoUA)-containing disaccharides variably sulfated with a higher proportion of GlcUA/IdoUA-GalNAc 4,6-O-disulfate, revealing complex CS/DS hybrid features. The hybrid chains showed neurite outgrowth-promoting activity of an axonic nature, which resembled the activity of squid cartilage CS-E and which was abolished fully by chondroitinase ABC digestion and partially by chondroitinase AC-I or B digestion, suggesting the involvement of both GlcUA and IdoUA in neuritogenic activity. Purified CS-H exhibited interactions in a BIAcore system with various heparin-binding proteins and neurotrophic factors (viz. fibroblast growth factor-2, -10, -16, and -18; midkine; pleiotrophin; heparin-binding epidermal growth factor-like growth factor; vascular endothelial growth factor; brain-derived neurotrophic factor; and glial cell line-derived neurotrophic factor), most of which are expressed in the brain, although fibroblast growth factor-1 and ciliary neurotrophic factor showed no binding. Kinetic analysis revealed high affinity binding of these growth factors and, for the first time, of the neurotrophic factors. Competitive inhibition revealed the involvement of both IdoUA and GlcUA in the binding of these growth factors, suggesting the importance of the hybrid nature of CS-H for the efficient binding of these growth factors. These findings, together with those from the recent analysis of brain CS/DS chains from neonatal mouse and embryonic pig (Bao, X., Nishimura, S., Mikami, T., Yamada, S., Itoh, N., and Sugahara, K. (2004) J. Biol. Chem. 279, 9765-9776), suggest physiological roles of the hybrid chains in the development of the brain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15385557     DOI: 10.1074/jbc.M404746200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Sugar-dependent modulation of neuronal development, regeneration, and plasticity by chondroitin sulfate proteoglycans.

Authors:  Gregory M Miller; Linda C Hsieh-Wilson
Journal:  Exp Neurol       Date:  2015-08-24       Impact factor: 5.330

Review 2.  The chemical neurobiology of carbohydrates.

Authors:  Heather E Murrey; Linda C Hsieh-Wilson
Journal:  Chem Rev       Date:  2008-05-02       Impact factor: 60.622

3.  A novel eliminase from a marine bacterium that degrades hyaluronan and chondroitin sulfate.

Authors:  Wenjun Han; Wenshuang Wang; Mei Zhao; Kazuyuki Sugahara; Fuchuan Li
Journal:  J Biol Chem       Date:  2014-08-13       Impact factor: 5.157

4.  Synthesis of Chondroitin Sulfate A Bearing Syndecan-1 Glycopeptide.

Authors:  Sherif Ramadan; Weizhun Yang; Zeren Zhang; Xuefei Huang
Journal:  Org Lett       Date:  2017-08-29       Impact factor: 6.005

5.  Glioma Cell Invasion is Significantly Enhanced in Composite Hydrogel Matrices Composed of Chondroitin 4- and 4,6-Sulfated Glycosaminoglycans.

Authors:  Meghan T Logun; Nicole S Bisel; Emily A Tanasse; Wujun Zhao; Bhagya Gunasekera; Leidong Mao; Lohitash Karumbaiah
Journal:  J Mater Chem B       Date:  2016-08-26       Impact factor: 6.331

6.  Intracerebral chondroitinase ABC and heparan sulfate proteoglycan glypican improve outcome from chronic stroke in rats.

Authors:  Justin J Hill; Kunlin Jin; Xiao Ou Mao; Lin Xie; David A Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

7.  Interaction of chondroitin sulfate and dermatan sulfate from various biological sources with heparin-binding growth factors and cytokines.

Authors:  Shuji Mizumoto; Duriya Fongmoon; Kazuyuki Sugahara
Journal:  Glycoconj J       Date:  2012-12-29       Impact factor: 2.916

8.  Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding.

Authors:  Gerdy B ten Dam; Els M A van de Westerlo; Anurag Purushothaman; Radu V Stan; Johan Bulten; Fred C G J Sweep; Leon F Massuger; Kazuyuki Sugahara; Toin H van Kuppevelt
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

9.  Cloning and characterization of a novel chondroitin sulfate/dermatan sulfate 4-O-endosulfatase from a marine bacterium.

Authors:  Wenshuang Wang; Wenjun Han; Xingya Cai; Xiaoyu Zheng; Kazuyuki Sugahara; Fuchuan Li
Journal:  J Biol Chem       Date:  2015-02-03       Impact factor: 5.157

10.  Determination of iduronic acid and glucuronic acid in sulfated chondroitin/dermatan hybrid chains by (1)H-nuclear magnetic resonance spectroscopy.

Authors:  Fuchuan Li; Shuhei Yamada; Ajaya K Shetty; Makiko Sugiura; Kazuyuki Sugahara
Journal:  Glycoconj J       Date:  2008-03-27       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.